The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis.
By I. Petit, D. Jin, Shahin Rafii. Trends in immunology, 2007
604 citations recorded by the source corpus.
Subfields: Hematology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/eb50ecd541bf1cc690aa2801ddaec051314f2f4d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
In Molecular Biology
In Oncology
Citations in the corpus
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective (2010, positive): “This process includes the CXCL12/CXCR4 axis, which has a critical role in stem cell migration (160).”
- The role of CXC chemokines and their receptors in cancer. (2008, background): “[138] I.”
- Platelet secretion: From haemostasis to wound healing and beyond (2015, background): “sprouting and tube formation in vitro and in vivo [94–96].”
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer (2010, positive): “CXCL12 plays a role in the mobilization and recruitment of these cells to the neoangiogenic niches supporting revascularization of ischemic tissue and tumor growth (10).”
- HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. (2008, methodology): “While VEGF is an important factor for the activation of MMP-9 in the bone marrow and subsequent mobilization of vascular progenitor cells (Hattori et al., 2001), SDF1a may be crucial for retaining CD45+ populations within the tumor (Grunewald et al., 2006 )( Petit et al., 2007 ).”